Related Experiment Video
Updated: Jan 14, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Therapies and Pipeline for Hepatitis B and Hepatitis D
James Lee1, Nishali Shah1, Rahul Kukreja1
1Department of Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
None:
This article provides a comprehensive overview of the current therapeutic approaches to managing hepatitis B virus infection. It begins with an outline of the goals of treatment, including viral suppression and prevention of liver disease progression. The article then delves into the current classes of antiviral agents used in clinical practice, such as nucleos(t)ide analogs (eg, tenofovir and entecavir) and pegylated interferon. The article then covers emerging therapies and novel agents under investigation, including capsid/core inhibitors, immune modulators, gene editing, and therapeutic vaccines. This article aims to inform health care professionals regarding the evolving landscape of hepatitis B treatment.
More Related Videos
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Retrovirus Life Cycles
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Microorganisms in Medicine and Therapeutics
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

